HLA-DRB1 antibody (FITC)
Quick Overview for HLA-DRB1 antibody (FITC) (ABIN7540140)
Target
See all HLA-DRB1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- FITC-Linked Anti-HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1) Polyclonal Antibody
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Immunogen
- abo_RPC167Hu01-Recombinant HLA Class II Histocompatibility Antigen, DRB1 Beta Chain (HLA-DRB1)
-
Isotype
- IgG
-
-
-
-
Application Notes
- For flow cytometry, the suggested use of this reagent is 1-5 μL per 10^6 cells in 100 μL volume. Optimal working dilutions could be determined by end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C, protected from prolonged exposure to light.
-
-
- HLA-DRB1 (Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
-
Alternative Name
- HLA Class II Histocompatibility Antigen, DRB1 Beta Chain
-
Background
- HLA-DRB1, MHCDRb1, HLADRb1, Major Histocompatibility Complex Class II DR Beta 1, HLA Class II Histocompatibility Antigen,DRB1-9 Beta Chain, HLA class II histocompatibility antigen, DRB1-15 beta chain
-
UniProt
- P01911
-
Pathways
- TCR Signaling, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-